APPB OTC
Applied Biosciences Corp.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -96.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$89K
-87.7% ▼
Gross Profit
-$318K
-210.8% ▼
Operating Income
-$693K
+77.6% ▲
Net Income
-$767K
+83.6% ▲
EPS (Diluted)
$-0.06
+83.5% ▲
EBITDA
-$725K
+80.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $46K | $198K | $707K | $723K | $89K |
| YoY Growth | +0.0% | +333.7% | +257.9% | +2.3% | -87.7% |
| Cost of Revenue | $6K | $156K | $522K | $437K | $407K |
| Gross Profit | $39K | $42K | $185K | $287K | -$318K |
| Gross Margin | 86.0% | 21.3% | 26.2% | 39.6% | -358.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $159K | $1M | $3M | $3M | $375K |
| Operating Expenses | $179K | $2M | $3M | $3M | $375K |
| Operating Income | -$516K | -$600K | -$3M | -$3M | -$693K |
| Operating Margin | -1132.5% | -303.5% | -374.3% | -427.1% | -781.3% |
| Interest Expense | $0 | $0 | $649K | $1M | $0 |
| Income Before Tax | -$516K | -$2M | -$3M | -$5M | -$900K |
| Tax Expense | $378K | $883K | $0 | $0 | $0 |
| Net Income | -$518K | -$2M | -$3M | -$5M | -$767K |
| Net Margin | -1136.4% | -1202.8% | -371.9% | -646.1% | -865.3% |
| EPS (Diluted) | $-0.04 | $-0.16 | $-0.22 | $-0.34 | $-0.06 |
| EBITDA | -$120K | -$2M | -$2M | -$4M | -$725K |
| Shares Outstanding | 12M | 15M | 12M | 14M | 14M |